Pay-For-Delay Ruling May Be Boon For Attys, Experts Say

Law360, Philadelphia (September 23, 2013, 10:53 PM EDT) -- As a Federal Trade Commission official applauded the U.S. Supreme Court’s recent ruling that patent law doesn't shield so-called pay-for-delay deals from antitrust scrutiny, patent attorneys emphasized Monday that the decision could ultimately hinder competition but would be a boon for litigators.

In a session during the Licensing Executive Society’s annual meeting, Nick Widnell, FTC deputy assistant director for the Bureau of Competition’s Anticompetitive Practices Division, attacked the practice of reverse payments from branded pharmaceutical companies to generic infringers, arguing that they lead to increase prices...
To view the full article, register now.